Go to: Spruson & Ferguson (Asia)

Download Profile in PDF

Principal/Patent Attorney
Chemical/Life Sciences Team
Email: martin.obrien@spruson.com

Martin O’Brien is a Principal of the firm, specialising in molecular biology and biotechnology. His practice primarily involves drafting and prosecuting patent applications, as well as considerable involvement in patent opposition matters, predominantly in the fields of biotechnology and biochemistry.

After obtaining his Bachelor of Science degree with First Class Honours, majoring in biochemistry and genetics, Martin was awarded a PhD from the University of Sydney. He undertook postdoctoral research at Royal Prince Alfred Hospital Sydney, investigating the genetics of alcohol metabolism and alcohol dependence, and joined Spruson & Ferguson in 1998.

Martin is a member of the Australian Society of Biochemistry and Molecular Biology and a member of the Intellectual Property Society of Australia and New Zealand. Martin is the co-author of a number of refereed scientific reports in international journals and has presented seminars on intellectual property issues.


Qualifications

	Bachelor of Science (Hons 1), University of Sydney
	Doctor of Philosophy, University of Sydney
	Master of Legal Studies, University of Technology, Sydney
	Diploma in Intellectual Property Practice, Academy of Education, The Institute of Patent and Trade Mark Attorneys of Australia
	Registered Australian Patent Attorney
	Registered New Zealand Patent Attorney
	Registered Australian Trade Mark Attorney

Articles by Martin O'Brien

	Federal Court of Australia Affirms Patentability of Isolated Nucleic Acids 15 February 2013
	The Gene Patents Debate in Australia - An Update 24 November 2011
	Senate Committee says NO to Gene Patents Bill 23 September 2011
	Transitional Provisions in the proposed IP Laws Amendment Bill 15 March 2011
	Significant Australian Intellectual Property Law Changes Proposed 4 March 2011
	Final Report of a Senate Committee Inquiry into Gene Patents 30 November 2010
	The Gene Patent Debate - Bill seeks to exclude biological materials from patentability 25 November 2010

Privacy Policy | Terms of Engagement | Disclaimer | Site Map | Contact Us | Spruson & Ferguson (Asia)